bladerunner - re rprx trial, the trial is being conducted in europe..bulgaria I believe. I have no clue why the PR doesn't have more specifics, but remember this is still just an interim analysis..I would imagine after complete 6 month data details will be released along with perhaps a cc (the plan is to obtain full 6 month data from this ongoing ph II prior to implementation of a US study in this indication)